Clinical and pathological characterisation of primary pulmonary hypertension in a dog

Veterinary Record

Volumn 154, Issue 25, 2004, Pages 786-789

  Glaus, T M ^a   Soldati, G ^a   Maurer, R ^b   Ehrensperger, F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; BUTIZIDE PLUS SPIRONOLACTONE; FUROSEMIDE; SPIRONOLACTONE;

AGE; ARTERIOLE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ASCITES; BLOOD VESSEL OCCLUSION; CALCULATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; DOG; DOG DISEASE; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; LUNG ARTERY PRESSURE; LUNG INSUFFICIENCY; NONHUMAN; ONSET AGE; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION;

CANIS FAMILIARIS;

EID: 3042734540     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.154.25.786     Document Type: Article

References (14)

1. BARMAN, S. A. & ISALES, C. M. (1998) Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1. Pulmonary Pharmacology and Therapeutics 11, 183-187
2. BERGER, M., HAIMOWITZ, A., VAN TOSH, A., BERDOFF, R. L. & GOLDBERG, E. (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. Journal of the American College of Cardiology 6, 359-365
3. EDWARDS, W. D. & EDWARDS, J. E. (1977) Clinical primary pulmonary hypertension: three pathologic types. Circulation 56, 884-888
4. FEIGENBAUM, H. (1993) Haemodynamic information derived from echocardiography. In Echocardiography. 5th edn. Ed H. Feigenbaum. Philadelphia, Williams & Wilkins. pp 181-215
5. FISHMAN, A. P. (1998) Pulmonary hypertension. In Hurst's The Heart. 9th edn. Eds R. W. Alexander, R. C. Schlant, V. Fuster. New York, McGraw-Hill. pp 1699-1717
6. FISHMAN, A. P. (2000) Changing concepts of the pulmonary plexiform lesion. Physiology Research 49, 485-492
7. GLAUS, T. M., HAUSER, K., HÄSSIG, M., LIPP, B. & REUSCH, C. E. (2003) Non-invasive measurement of the cardiovascular effects of chronic hypoxaemia on dogs living at moderately high attitude. Veterinary Record 152, 800-803
8. GURTNER, H. P. (1979) Pulmonary hypertension, 'plexogenic pulmonary arteriopathy' and the appetite depressant drug aminorex: post or propter? Bulletin de Physio-Pathologie Respiratoire 15, 897-923
9. JOHNSON, L., BOON, J. & ORTON, E. C. (1999) Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992-1996. Journal of Veterinary Internal Medicine 13, 440-447
10. LEE, S., SHROYER, K. R., MARKHAM, N. E., COOL, C. D., VOELKEL, N. F. & TUDER, R. M. (1998) Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. Journal of Clinical Investigation 101, 927-934
11. MARTIN, M. W. S., GODMAN, M., LUIS FUENTES, V., CLUTTON, R. E., HAIGH, A. & DARKE, P. G. G. (1992) Assessment of balloon pulmonary valvuloplasty in six dogs. Journal of Small Animal Practice 33, 443-449
12. RUBIN, L. J. (1997) Primary pulmonary hypertension. New England Journal of Medicine 336, 111-117
13. SCHOBER, K., BAADE, H., LUDEWIG, E., AUPPERLE, H. & OECHTERING, G. (2002) Cor pulmonale bei Terrierhunden mit chronisch progressiver idiopathischer Lungenfibrose: 19 Fälle (1996-2001). Tierärztliche Praxis 30, 180-189
14. YEAGER, M. E., HALLEY, G. R., GOLPON, H. A., VOELKEL, N. F. & TUDER, R. M. (2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circulation Research 88, e2-e11